India Exchange Filings

Gaudium IVF Q2 FY27 Earnings and Board Highlights

Gaudium IVF and Women Health Ltd reports Q2 FY27 consolidated revenue of ₹37.41 crore and net profit of ₹9.41 crore

  • Revenue rose 93.1% sequentially and 17.9% year on year; net profit increased 430.3% sequentially and 0.4% year on year.
  • Estimated EBITDA margin was 36.0%; auditors issued an unmodified limited-review conclusion. Q2 FY26 comparative figures were not reviewed.
  • Board approved proposed changes to six locations and the establishment schedule for 19 IPO-funded IVF centres; the ₹50 crore allocation is unchanged, with completion planned by FY29, subject to shareholder approval.
  • Dr. Ravish Manchanda was appointed National Head – Operations Expansion & Strategy.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.